Genetic Influences on Statin Blood Concentrations in African Americans

NCT01569867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501

Last updated 2022-10-13

No results posted yet for this study

Summary

This study intends to determine the effects of genetic polymorphisms on statin response and daily systemic exposure (24-hour area under the time-concentration curve) of statins in African-American patients.

Conditions

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH
  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH
  • Ohio State University

    lead OTHER

Principal Investigators

  • Joseph P Kitzmiller, MD PhD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2022-01-31
Completion
2022-04-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569867 on ClinicalTrials.gov